Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

REGISTER for free or LOG IN to view this content

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

We Recommend